Skip Ribbon Commands
Skip to main content

February 11
Allergy Partners will be here, will you?!?

Fredericksburgs largest sand box, Meeting a Minion and train rides  are just the tip of the iceberg of fun kids can have at the Annual Kids Expo Saturday and Sunday, February 13 and 14th at the Fredericksburg Expo Center, Fredericksburg VA. Also for the kids there are a petting zoo,  Inflatables – by KD’z Kidz World,  and more. Grownups can do some one-stop-shopping for the latest products and services for growing families from national and local companies. More information and advance tickets visit:

January 25
Weather Update

Our Fredericksburg office will be opening at 8:30am Tuesday, January 26, our Stafford office will be open normal hours. ​

January 24
Weather Update for Monday, January 25th

Due to inclement weather our Stafford office will be CLOSED Monday, January 25th, our Fredericksburg office will be opening at 10am and closing at 5pm, please continue to check our Facebook Page and website for up to date information. ​

January 24
Delayed Opening

Due to inclement weather, both our Fredericksburg and Stafford offices will be opeing at 10 am, please continue to check our Facebook page and Website for up to date information. ​

January 21
Weather Alert

Due to the impending weather, Allergy Partners of Fredericksburg will be closing at 1pm on Friday, January 22, please continue to check our website and Facebook page for up to date information. ​

January 04
Find out what you need to know about Food Allergies

See our Ask the Expert article in the January issue of Fredericksburg Parent Magazine (or online at

We'll also answer your questions LIVE during Ask the Expert, January 14 at 8PM at

QA Capture.JPG

December 31
New Year's Eve Hours

Our office will be closing at 5 pm today, with the last shot being given at 4:30 pm, we hope everyone has a Happy New Year!


December 29
The myth: Regular use of inhaled corticosteroids to treat asthma will weaken my lungs.

The science:

Systemic corticosteroids were first shown to be effective in the treatment of acute asthma in 1956.  Since the 1970s the use of inhaled corticosteroids (applied directly to the lungs with inhaler devices) has been proven to treat asthma with fewer side effects than systemic corticosteroids. Inhaled corticosteroids have consistently been shown in studies to decrease asthma symptoms, improve lung function, reduce asthma exacerbations (resulting in less emergency department visits and hospitalizations), decrease risk of death and reduce the need for rescue asthma medications and oral corticosteroids. Inhaled corticosteroids are the preferred medications for managing persistent asthma in all ages, and the dose is based on the severity of the asthma. 
When used appropriately, inhaled corticosteroids have few adverse effects at low and medium doses. The most common side effects include hoarseness of voice and oral thrush, both of which can be reduced with proper inhaler technique and rinsing of mouth after use. The higher dosages of inhaled corticosteroids can have more important side effects, including the ability to suppress the adrenal axis and even have long term effects on height when used in childhood (approximately 1.2 centimeters in the best study).  However, the higher dosages of inhaled corticosteroids are used to treat only severe asthmatics, who would often require repeated doses of oral corticosteroids to open their airways and the risk to benefit ratio may still be in favor of the use of inhaled corticosteroids.  Each patient is always unique and asthma is best cared for by a physician who specializes in asthma care. 
So is the myth busted or true?
Thankfully though, there is no dose of inhaled corticosteroid that has been shown to weaken lungs. 


December 11
Myth or Fact: Are shellfish and iodine allergies related?

Find out what Allergy Partners has to say about this popular question.

December 07
Monoclonal Antibody Therapy

On the News.

The FDA recently approved a new monoclonal antibody for add on therapy for the treatment of severe asthma in patients older than 12 years of age.


How Does it Work?
Mepolizumab, which will also be known by its trade name Nucala, is a monthly injection of a monoclonal antibody that inhibits interleukin-5. Interleukin-5 is a cytokine which helps regulate eosinophils. Eosinophils are white blood cells which can be a prominent feature of several forms of asthma, especially allergic and severe persistent asthma. The allergic reaction to an antigen often involves the development of eosinophils. The underlying damage to the respiratory airway is often contributed by vast amounts of eosinophil migration; increase up regulation of eosinophil production; adhesion of eosinophils to the airway; and release of eosinophils toxic products. Up to now the therapy to control eosinophils often rely on inhaled and systemic steroids.


Is It For Me?
According to the World Health Organization (WHO) estimates there are 235 million people living with asthma worldwide. It is estimated that as many as 10% of those patients who have severe persistent asthma cannot achieve good control with the available inhaled anti-inflammatory medicines and may need chronic systemic steroids. It is this group of patients that new therapy may provide a safe alternative for additional control. To date specialists have been able to use a monoclonal antibody known as the Xolair also known as Omalizumab which targeted the IgE antibody seen in some forms of asthma. With this recent FDA approval, specialists such as the physicians at Allergy Partners will be better able to select the appropriate therapy for the more difficult asthma patient.
Side Effects.


The most common side effects of Mepolizumab include headaches, upper respiratory infections, asthma, local injection site reactions, back pain and fatigue.


1 - 10Next

 About this blog


Welcome to our blog site! Stay tuned to get the latest news. We will share tips and techniques for living with and managing your Allergies & Asthma. We look forward to sharing useful resources with our patients!